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Abstract
Introduction
The WHO yaws eradication strategy consists of one round of total community treatment
(TCT) of single-dose azithromycin with coverage of > 90%.The efficacy of the strategy to
reduce the levels on infection has been demonstrated previously in isolated island communi-
ties in the Pacific region. We aimed to determine the efficacy of a single round of TCT with
azithromycin to achieve a decrease in yaws prevalence in communities that are endemic for
yaws and surrounded by other yaws-endemic areas.
Methods
Surveys for yaws seroprevalence and prevalence of skin lesions were conducted among
schoolchildren aged 5–15 years before and one year after the TCT intervention in the
Abamkrom sub-district of Ghana. We used a cluster design with the schools as the primary
sampling unit. Among 20 eligible primary schools in the sub district, 10 were assigned to the
baseline survey and 10 to the post-TCT survey. The field teams conducted a physical exam-
ination for skin lesions and a dual point-of-care immunoassay for non-treponemal and trepo-
nemal antibodies of all children present at the time of the visit. We also undertook surveys
with non-probabilistic sampling to collect lesion swabs for etiology and macrolide resistance
assessment.
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Results
At baseline 14,548 (89%) of 16,287 population in the sub-district received treatment during
TCT. Following one round of TCT, the prevalence of dual seropositivity among all children
decreased from 10.9% (103/943) pre-TCT to 2.2% (27/1211) post-TCT (OR 0.19; 95%CI
0.09–0.37). The prevalence of serologically confirmed skin lesions consistent with active
yaws was reduced from 5.7% (54/943) pre-TCT to 0.6% (7/1211) post-TCT (OR 0.10; 95%
CI 0.25–0.35). No evidence of resistance to macrolides against Treponema pallidum subsp.
pertenue was seen.
Discussion
A single round of high coverage TCT with azithromycin in a yaws affected sub-district adjoin-
ing other endemic areas is effective in reducing the prevalence of seropositive children and
the prevalence of early skin lesions consistent with yaws one year following the intervention.
These results suggest that national yaws eradication programmes may plan the gradual
expansion of mass treatment interventions without high short-term risk of reintroduction of
infection from contiguous untreated endemic areas.
Author summary
In this study, we provided a single round of total community treatment (TCT) with azi-
thromycin to the population of a sub-district in Ghana (16,287 people) that is endemic for
yaws and surrounded by other yaws-endemic communities to determine whether a sus-
tained decrease in yaws prevalence could be achieved up to one year after the intervention.
The efficacy of TCT was assessed by performing a clinical evaluation and serological test-
ing of any yaws-like lesions found as well as serological screening of asymptomatic school-
children aged 5–15 years pre-TCT and at one year post-TCT. The results indicate that
after a single round of high coverage TCT (89%) with azithromycin, the prevalence of
active and latent yaws was significantly reduced. We also found that the use of a dual
point-of-care immunoassay to detect non-treponemal and treponemal antibodies among
school-going children is a practical alternative to laboratory-based serological testing to
evaluate the effectiveness of yaws interventions in resource-poor settings.
Introduction
Yaws is a chronic, relapsing, neglected tropical disease caused by Treponema pallidum spp. per-
tenue, a spirochaete closely related to that which causes syphilis [1]. The disease is currently
reported from 13 of the 85 countries previously considered endemic in the 1950s, with an esti-
mated 89 million people living in the affected districts [2]. Yaws is usually acquired by children
in impoverished communities in tropical and subtropical countries when traumatized skin
comes into contact with another person’s early infectious lesion exudate, often during play.
The disease affects mostly children aged under 15 years. The frequency of infection appears to
be higher in boys than in girls [3].
Primary yaws lesions develop at the site of initial inoculation after an incubation period of
9–90 days. These lesions are initially papules, which can develop into papillomata and eventu-
ally ulcerate, and are most frequently found on the lower legs and ankles and, less frequently,
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on the skin of the upper limbs and elsewhere on the body. If left untreated, the disease may
progress to the secondary stage, which is characterized by multiple skin lesions as well as ostei-
tis and periostitis of the bones underlying the skin lesions. Untreated disease may spontane-
ously resolve clinically and enter a period of latency prior to the development of non-
infectious gummas of the skin, cartilage and bone, resulting in the destructive, often disfigur-
ing, lesions of late yaws [4].
During the 1950s and 1960s, the World Health Organization (WHO) and the United
Nations Children’s Fund (UNICEF) led a global campaign to eradicate the disease by provid-
ing mass treatment to affected communities using single intramuscular injections of long-act-
ing penicillin. The strategy was based on the need to screen at least 90% of the population,
treat the entire reservoir of treponemal infection (including those with clinical disease, latent
infection and contacts) and to perform periodic surveys at 6–12 months to identify and treat
missed, new and imported cases [5]. The criteria for eradication were defined by the WHO
Expert Committee on Venereal Infections and Treponematoses in 1960 as the absence of an
indigenous infectious case in the population for three consecutive years and absence of any
new seroreactor aged under 5 years [6]. The implementation of the global yaws eradication
programme between 1952–1964 reduced the prevalence of infection by approximately 95%
(from 50 million to 2.5 million cases) worldwide, indicating that the mass treatment approach
using benzathine penicillin was highly successful [7]. In some countries such as Haiti and
Nigeria, experience showed that one round of mass treatment with coverage of> 90% signifi-
cantly reduced the prevalence of infectious cases by approximately 98% within 12 months [8,
9]. Despite the success of the campaign, the ultimate goal of eradication could not be achieved
owing to several factors including the failure of many countries to adequately integrate active
surveillance activities into the local health system after the mass treatment campaigns ended,
complacency, limited resources, lack of political will and many new competing health priori-
ties including the shifting of the dedicated mobile teams for yaws eradication to deal with
diseases such as smallpox and cholera [5]. This situation led to the resurgence of yaws in sev-
eral countries in the late 1970s, prompting the World Health Assembly to adopt resolution
WHA31.58 [10] which called on countries to take the necessary measures to interrupt trans-
mission at the earliest possible time. Despite the possibility that yaws transmission has ceased
in a number of countries that were endemic in the 1950s but not confirmed, only India has
recently been formally certified by WHO as yaws-free [11]. The disease still remains endemic
in many countries in West and Central Africa, South-East Asia and the Western Pacific [12].
In 2012, the finding that a single oral dose of azithromycin was as effective as injectable pen-
icillin for the treatment of yaws [13] prompted WHO to revisit the global eradication of the
disease. In 2012, WHO published a roadmap on neglected tropical diseases that targeted yaws
eradication by 2020 [14]. In the same year, WHO devised a new yaws eradication strategy (the
Morges Strategy) [15]. The strategy recommends total community treatment (TCT, equivalent
to mass treatment for other neglected tropical diseases) of affected communities with single
doses of azithromycin followed by ongoing active surveillance, case-finding and treatment of
missed, new and imported cases and their contacts (household, neighborhood and school play-
mates) through a health system approach. Depending on the initial treatment coverage and
accessibility to the endemic communities, the strategy recommends repeat surveys to identify
and treat any new infectious cases or in response to localized outbreaks (using total targeted
treatment, TTT). The feasibility of global yaws eradication and the progress made in imple-
menting the Morges Strategy have previously been reported [16, 17].
In 2015, the first empirical data of the impact of mass treatment with azithromycin on dis-
ease transmission became available. A study carried out in Lihir, Papua New Guinea (PNG)
demonstrated that mass treatment with azithromycin to the population of yaws-endemic
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island communities resulted in a significant decrease in the prevalence of clinically early yaws
lesions and a decrease in reactive serological markers for the disease [17]. Similar findings
have emerged from a study in the Solomon Islands that evaluated the secondary benefits of
mass treatment of trachoma using 20 mg/kg azithromycin on the prevalence of yaws [18].
However, despite the encouraging results obtained in these countries, focused mass treatment
campaigns are, theoretically, more likely to succeed in isolated island communities where
the risk of reintroduction of infection in the treated population from untreated adjoining com-
munities is less likely. Since the disease is also endemic in many countries with affected
communities spread over a contiguous land mass, it is also important to determine whether
high coverage with azithromycin mass treatment in a defined area can result in a sustained
decrease in infectious yaws up to one year after the intervention. This is also important, since
the resources available to yaws eradication programmes in many countries are limited, result-
ing in an inevitable delay or progressive expansion of the implementation of the programme
to adjoining endemic areas that could act as a source of re-infection for the initial target
communities.
In this study, we aimed to assess the impact of a single round of TCT with azithromycin
using two markers of infection among school-going children in the target communities before
and one year after the intervention. We measured the prevalence of dually seropositive for
non-treponemal and treponemal serological markers, and the prevalence of active yaws-like
lesions among children. A secondary objective was to establish the etiology of active yaws-like
lesions among schoolchildren using sensitive molecular techniques and to assess the occur-
rence of mutations associated with azithromycin resistance among T. pallidum spp. pertenue
positive lesions in the local population.
Methods
The study protocol was approved by the ethics committee of the Ghana Health Service, Minis-
try of Health (GHS-ERC-05/01/13). Written informed consent was obtained from parents and
where they were unable to provide consent, teachers provided written consent on their behalf,
which is normal practice for mass treatments campaigns in Ghana. Prior to the initiation of
mass treatment with azithromycin, information sessions were held with the regional director-
ate of health services, the district political authorities and communities about the study in
order to gain their support. The local radio was used to inform the entire district about the
mass treatment campaign. Health workers and village volunteers distributed the WHO yaws
picture booklets [19] to households and schools as part of the social mobilization effort.
Study area and population
We conducted a prospective observational study in the Abamkrom sub-district, West Akim
district of the Eastern Region of Ghana between October 2013 and December 2014. The sub-
district is highly endemic for yaws (Fig 1) [20]. The total population of the sub-district in mid-
2013 was estimated to be 16,287 people, i.e. 7.7% of the population of the district as a whole
(212 282 people). The eligible population for mass treatment was everyone older than 6
months of age, excluding pregnant women (as decided by the local study team), 15,310 people
in total. The sub-district has 5 health centres, 24 primary schools and 36 communities. The
total population of children 5–15 years registered in primary schools that were targeted for
impact assessment surveys was 2,909 children. Each community has a village health volunteer
who is responsible for monitoring and reporting health events. These volunteers are used for
mass drug administration for other neglected tropical diseases. The total eligible population
(aged 6 months) living in the 36 communities was targeted to receive mass treatment with
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azithromycin as part of the study. The school attendance rate in the sub-district among chil-
dren aged 5–15 years has been estimated to be 47.6%.
Mass azithromycin treatment
Prior to the implementation of the study, the health workers and village volunteers were
trained on the objectives of the study, recognition of yaws-like lesions, implementation and
data collection tools. The TCT programme was conducted by 13 teams of two trained volun-
teers drawn from affected communities who were supervised by local health-care workers or
members of the national yaws eradication programme. During a five-day period in Novem-
ber–December 2013, the teams offered azithromycin tablets (purchased by WHO from Medo-
pharm, Chennai, India) at a single oral dose of 30 mg/kg per body weight (maximum 2 g) to
all members of the 36 targeted communities aged 6 months and above at no cost to the partici-
pants. The tablets (500g strength) were administered to the eligible population according to
age as described in the WHO Morges Strategy document [15]. For children aged under 6
years, the tablets were crushed and mixed with water. The volunteers directly observed treat-
ment of participants, maintained tally sheets; they marked the fingers of treated participants
with indelible ink to document the administration of the medicines, and observed participants
for approximately one hour after ingestion of the medication, reporting any adverse events
that could be related to azithromycin treatment. The supervisors collected the tally sheets daily
Fig 1. Maps showing position of Abamkrom sub-district within the West Akim district in Ghana and geographical distribution of schools sampled
pre- and post-TCT.
https://doi.org/10.1371/journal.pntd.0006303.g001
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and followed up any adverse drug reactions reported by volunteers. TCT coverage rates were
calculated using the number of persons treated according to the tally sheets divided by the
total population.
School and participants selection
We used cluster sampling with individual schools as the cluster unit. Eligibility for inclusion
was met by 20 primary schools with a population larger than 100 children among 24 schools
located in the sub-district. The schools were randomly assigned to either the pre- or post-
TCT evaluation surveys. Therefore, the sets of schools for pre- and post- TCT surveys were
mutually exclusive and schools could not be chosen repeatedly for more than one survey.
Every child present at the time of our visit to the schools selected was invited to participate in
the study.
Procedures
The primary outcome was prevalence of sero-positivity, defined as dually non-treponemal and
treponemal antibody positivity using a point-of-care test among symptomatic or asymptom-
atic children. Secondary outcomes, were the prevalence of suspected yaws, defined as a child
with a history of residence in an endemic area who presented with clinically active (visible)
yaws-like lesions, and the prevalence of serologically-confirmed yaws, defined as a suspected
case with a dually-positive serological test result for non-treponemal and treponemal
antibodies.
In October 2013, before the mass treatment campaign (November–December 2013), we
conducted a baseline assessment survey in 10 randomly selected primary schools and every
child present, 943 children in total, was enrolled. One year after the intervention (November–
December 2014), every child from a further group of 10 randomly selected schools, 1211 chil-
dren in total, were selected for an identical post-intervention assessment of impact survey. Fig
1 shows the geographical distribution of these schools within the sub-district and Fig 2 the
flowchart of the study design.
During both assessments, all children were examined clinically for skin lesions consistent
with early infectious yaws (i.e. skin papilloma, chronic solitary or multiple skin ulcerations)
and a specimen of capillary blood was collected from all, symptomatic and asymptomatic, par-
ticipants to perform a point-of-care immunoassay for antibody to yaws infection. All children
with active yaws-like lesions detected during either the initial or post-TCT assessments or
those who were asymptomatic but had a dually non-treponemal and treponemal antibody-
positive result on initial field screening were treated with a single dose of azithromycin (30
mg/kg) and followed up for adverse events.
Serological testing
A point-of-care immunoassay, developed for the serological diagnosis of syphilis, that can
simultaneously detect both non-treponemal and treponemal antibodies (DPP Syphilis Screen
and Confirm Assay, Chembio Diagnostic Systems, Medford, NY, USA) [21–23] was used to
test 10 μl samples of capillary blood obtained by finger prick from each of the schoolchildren
who were included in the selected pre- and post-TCT schools. In each case, the child’s finger
was cleaned with an alcohol swab, the skin punctured with a lancet and the capillary blood col-
lected in a pre-graduated micropipette supplied in the test kit. Thereafter the test was per-
formed directly in the field according to the manufacturer’s instructions.
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Surveys to determine the etiology of active yaws-like lesions and mutations
for azithromycin resistance
We conducted clinical surveys to collect lesion swabs for PCR testing before and one year after
TCT. Due to the low number of T. pallidum PCR positive cases detected in Abamkrom sub-
district before the intervention, we decided to extend the baseline study to the entire West
Akim district (8 sub-districts, 212 282 people). We had 8 teams, one in each sub-district, that
examined the skin of schoolchildren aged less than 15 years of age. The sampling for this study
was non-probabilistic; teams visited enough schools and enrolled all consecutive eligible chil-
dren to achieve 150 symptomatic children sampled. If they identified any skin lesion, the child
Fig 2. Flowchart of school and pupil selection.
https://doi.org/10.1371/journal.pntd.0006303.g002
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was invited for diagnosis, swab sample collection and treatment after their parents or guard-
ians provided written informed consent. Similar procedures were used for post-TCT surveys
that were conducted only in the Abamkrom sub-district.
Children with suspected yaws had their lesions photographed and specimens taken directly
from the largest papilloma or ulcer after cleansing with sterile saline using either a sterile plas-
tic curette (Ear Curette, Sklar Instruments, West Chester, PA, USA) or sterile dacron-tipped
swabs (Medical Wire & Equipment, Corsham, UK) for PCR testing. PCR-confirmed yaws was
defined as a suspected case with a positive PCR detection of DNA of the polymerase I gene
and/or the T. pertenue-specific 23S rRNA gene sequence on material collected from suspected
lesions [24].
Scrapings from papillomata and swabs taken from the bases of skin ulcerations were
expressed into 1.2 ml of Assay-Assure nucleic acid transport medium (Thermo Fisher Scien-
tific, Waltham, MA, USA). All specimens were stored frozen at −20˚C before shipping, on dry
ice, to the WHO Collaborating Centre for Reference & Research in Syphilis Serology at the
Centers for Disease Control in Atlanta, GA, USA. Genomic DNA was extracted from 350 μl
aliquots of assay-assure samples using the iPrep PureLink gDNA blood kits (Life Technologies,
Grand Island, NY, USA) and iPrep purification instrument.
The specimen DNAs were originally screened with TaqMan-based real-time 4-plex poly-
merase chain reaction (PCR) targeting tp858 and two areas of the tprl (tp620) [25]. However,
due to the discovery of primer binding site mutation (i.e. some strains may be undetectable by
the PCR used), [26] we changed to a more sensitive PCR strategy and all specimens were re-
tested using a real-time PCR targeting the DNA polymerase I gene (polA, tp0105) of patho-
genic treponemes (which detects all 3 T. pallidum subspecies) [24] and a real-time 3-plex PCR
that detects the two 23S rRNA point mutations (A2058G and A2059G) associated with macro-
lide resistance in T. pallidum described previously [27]. If a specimen tested positive by polA-
PCR and/or 23S rRNA PCR (wild type or mutant), then we used the TaqMan-based real-time
4-plex PCR to differentiate T. pallidum spp. pertenue from spp. pallidum and endemicum [25].
A nested-PCR and sequencing of a portion of tp858 were used to resolve discrepant results
among those three assays and to confirm the presence of T. pertenue–specific DNA sequences.
All DNA samples were tested for Haemophilus ducreyi (which had previously been detected
in yaws-like lesions in PNG, Ghana, Vanuatu and the Solomon Islands [28–31]) and Mycobac-
terium ulcerans (the causative bacterium of Buruli ulcer, known to be endemic in the region)
using specific sequences (hemolysin gene, HdhA) and Insertion Sequence (IS) 2404 respec-
tively in a real time duplex PCR [32,33]. Genomic DNA samples purified from H. ducreyi or a
M. ulcerans culture (kindly provided by Dr. Anthony Ablordey, Noguchi Memorial Institute
for Medical Research, University of Ghana, Legon, Ghana) were used as the positive controls
for PCR assays. At least one no-template-control (NTC) and one positive control were
included in every test run. The analytical sensitivity of the duplex PCR assay is approximately
10–100 copies per reaction and the analytical specificity was assessed using DNA from a panel
of organisms including commensal and pathogenic microbes found in the genitourinary tract
and as part of the normal skin flora. All real-time multiplex PCR assays were performed on a
Rotor-Gene Q real-time PCR instrument (Qiagen Inc.,Valencia, CA, USA).
In addition, serum samples were obtained from venous blood collected from all children
with active lesions, for laboratory-based testing. These were stored frozen at −20˚C and trans-
ported on dry ice to the WHO Collaborating Centre for Reference & Research in Syphilis
Serology, where they were tested using a quantitative rapid plasma reagin (RPR) test (Alere
North America, Inc., Orlando, FL, USA) and a T. pallidum passive particle agglutination assay
(TPPA, Fujirebio Diagnostics Inc., Malvern, PA, USA).
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Statistical analysis
Data were entered in Microsoft Access software, version 15.0 (Microsoft, Redmond, WA,
USA) at the Ministry of Health, Ghana. The integrity of the data was verified by using a double
data entry process. The primary outcome was change in prevalence of dual seropositivity fol-
lowing TCT, secondary outcomes were changes in rates of prevalence of suspected cases with
lesions and change in prevalence of cases with lesion and seropositivity. We calculated that a
sample size for the pre- and post-TCT surveys of at least 854 schoolchildren aged 5–15 years
(EPI INFO 2000 sample size calculator) was required to detect a reduction by 45% in yaws
seroprevalence among students before and after TCT intervention with a 95% confidence
interval (CI) and 80% power. A design effect of 2 for the cluster sampling method was used to
calculate the power [34,35]. The average number of children among the 24 schools of the sub-
district is 145.5, therefore we considered that at least 10 schools had to be sampled at each
survey.
We calculated prevalence rates and 95% confidence intervals using the clustered sandwich
estimator to control the variability of clusters. We evaluated the changes in yaws seropreva-
lence, and prevalence of yaws-like lesions among the schoolchildren sampled before and one
year after TCT using logistic regression models controlling the variance-covariance matrix
(VCE) corresponding to the parameter estimates. We reported the standard errors of parame-
ter estimates as the square root of the variances of the VCE. For these, we use the option cluster
in the calculus of Odds Ratios with the logistic regression models. We calculated Odds Ratios
(post- compared to pre- TCT) for positive serology or clinical findings. The differences in the
prevalence rates were considered statistically significant when two-sided p-values were less
than 0.05. The statistical analysis was performed with Stata StataCorp. 2017 (Stata Statistical
Software: Release 15. College Station, TX: StataCorp LLC)
Results
Mass treatment with azithromycin
During the 5-day community-based mass treatment campaign, 14 548 (89%) of 16,287 resi-
dents in the sub-district received a single oral dose of azithromycin. Individuals who were not
eligible for treatment (977, 6.0%), or absent during the mass treatment (762, 4.7%) accounted
for 10.7%. of the total population (16 287) of the sub-district. There were no severe adverse
events attributable to the study drug; only 45 (0.3%) of the 14 548 participants treated reported
mild to moderate self-limiting adverse events including abdominal discomfort, nausea and
vomiting.
Demographics of the surveyed schoolchildren
Of the 943 children examined at schools before the community-based mass treatment cam-
paign, 487 (51.6%) were male, and a similar proportion of males was found among those
examined at schools after the TCT (632 /1211, 52.2%). The mean (SD) age of the pre-TCT
schoolchildren (10.5 [2.5] years) compared with that of the post-TCT children (9.4 [3.6] years)
was not significantly different.
Pre- and post-TCT clinical and serological results
The prevalence rate of dual seropositivity in the DPP test decreased significantly, from 103/943
(10.9% 95% CI 6.5–17.5) among children in the pre-TCT survey to 27/1211 (2.2%, 95%CI 1.3–
3.7; OR 0.19, 95%CI 0.09–0.37) in the post-TCT survey (Table 1). In addition, the prevalence
rate of serology confirmed yaws-like active lesions among schoolchildren was significantly
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reduced from a pre-TCT rate of 54/943 (5.7% 95%CI 3.2–9.9) to 7/1211 (0.6% 95%CI 0.2–1.6;
OR 0.10, 95%CI 0.25–0.35) in the sample of schoolchildren examined one year following the
TCT.
Results of PCR on lesion swabs to determine etiology
The results of PCR testing obtained from the children with active lesions in the extended inter-
vention area pre- TCT are shown in Table 2. Among 158 children with active skin lesions sam-
pled before mass treatment, 29/158 (18.4%) tested positive for T. pertenue-specific DNA
sequence (none of which contained mutations associated with azithromycin resistance) and
45/158 were H. ducreyi positive including 7/158 lesions that were dually T. pertenue and H.
ducreyi-PCR positive. M. ulcerans-specific DNA sequences were not detected in any specimen
obtained from lesions, either pre- or post-TCT. In the Abamkrom sub-district 3/53 (5.7%)
sampled cases pre-TCT were T. pertenue-PCR positive (Table 3), compared with 0/49 (0.0%)
of specimens sampled one year after mass treatment while the proportion of H. ducreyi-posi-
tive ulcers remained largely unchanged.
Table 1. Changes in seroprevalence, prevalence of skin lesions and serologically confirmed skin lesions among schoolchildren in the Abamkrom sub-district of
Ghana, before and one year after TCT with 30 mg/kg azithromycin.
Burden of disease Pre-TCT number (%) 95% CI Post-TCT number (%) 95% CI Odds Ratio (95% CI)
Yaws seroprevalence (dually-positive DPP
rapid test)
103/943 (10.9%) (6.5%-17.5%) 27/1211 (2.2%) (1.3%-3.7%) 0.19 (0.09–0.37)
Prevalence of skin lesions 337/943 (35.7%) (30.8%-40.9%) 223/1211 (18.4%) (14.1%-23.6%) 0.41 (0.31–0.52)
Prevalence of yaws-like lesions with a dually
positive DPP rapid test
54/943 (5.7%) (3.2%-9.9%) 7/1211 (0.6%) (0.2%-1.6%) 0.10 (0.25–0.35)
https://doi.org/10.1371/journal.pntd.0006303.t001
Table 2. Patterns of seroreactivity (RPR and TPPA laboratory-based tests) among children with active skin lesions consistent with yaws, by detection of T. pertenue
and H. ducreyi-specific DNA sequences, pre- TCT in the entire West Akim district (8 sub-districts).
Pattern of
seroreactivity
Pre-TCT
T. pertenue-PCR + no.+/total
(%)
T. pertenue- and H. ducreyi-PCR + no.+/total
(%)
H. ducreyi-PCR+ no.+/total
(%)
PCR negative no.−/total
(%)
TPPA+/RPR+ 20/57 (35.1%) 6/57 (10.5%) 7/57 (12.3%) 24/57 (42.1%)
TPPA+/RPR- 1/8 (12.5%) 1/8 (12.5%) 2/8 (25.0%) 4/8 (50.0%)
TPPA−/ RPR+ 0 0 0 0
TPPA−/RPR- 1/93 (1.1%) 0 29/93 (31.2%) 63/93 (67.7%)
Total 22/158 (13.9%) 7/158 (4.4%) 38/158 (24.1%) 91/158 (57.6%)
https://doi.org/10.1371/journal.pntd.0006303.t002
Table 3. Results of PCR in specimens collected in the Abamkrom sub-district.
PCR analysis Pre-TCT Post-TCT OR (95% CI)
T. pertenue-PCR + no.+/total (%) 3/53 (5.7%) 0/49 (0.0%) NA
H. ducreyi-PCR+no.+/total (%) 12/53 (22.6%) 14/49 (28.6%) 0.73 (0.27–1.96)
M. ulcerans- PCR+no.+/total (%) 0/53 (0.0%) 0/49 (0.0%) NA
Macrolide resistant T. pertenue no.+/total (%) 0/3 (0.0%) 0/0 (0.0%) NA
PCR negative no.+/total (%) 39/53 (73.6%) 35/49 (71.4%) 1.11 (0.42–2.91)
https://doi.org/10.1371/journal.pntd.0006303.t003
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Of the 158 blood samples collected pre-TCT from children with active lesions that under-
went serological testing at the CDC laboratory (Table 2), 57 (36.1%) showed reactivity in both
the non-treponemal and treponemal tests, and 8 (5.1%) were reactive for treponemal antibody
alone. Among dually reactive specimens, only 7/57 (12.3%) had RPR titres1:4, while the
remaining 50/57 (87.7%) sera exhibited titres between 1:8 and 1:128. The agreement between
T. pertenue-PCR and serologic assays was high. However, RPR and TPPA were positive in 31
children with lesions that were T. pertenue-PCR negative (24 all PCR tests negative, 7 H.
ducreyi-PCR positive; false positivity rate 31/63, 49.2%) which can be explained because serol-
ogy remains detectable in serofast status.
Discussion
Our study demonstrates that the provision of mass azithromycin administration given as a sin-
gle oral dose of 30 mg/kg, up to a maximum dose of 2 g, is effective in reducing both the rates
of seropositivity and the presence of serologically positive skin lesions consistent with yaws.
Our results support the findings of earlier publications from PNG [17] and the Solomon
Islands [18] and for the first time provides information on the efficacy of the Morges Strategy
in an area that was geographically contiguous with neighboring endemic areas, unlike the pre-
vious studies. In addition, we used potentially more operationally feasible approach compared
to the studies in the Pacific countries to measure the impact of one round TCT by focusing on
the school-going population. However, we suggest that if this approach is used, school atten-
dance rate should be>75% like in lymphatic filariasis surveys.
One year after TCT, we recorded a reduction in the prevalence of active yaws-like skin
lesions among schoolchildren living in the targeted communities which was consistent with a
reduction of passively detected suspected yaws cases in the same sub-district area (from 103
cases in 2012 to 20 in 2014) recorded in the routine reporting system (DHIMS2) of the Minis-
try of Health. Although the sample size was extremely small, we were unable to detect T. palli-
dum spp. pertenue using PCR test in any lesions that were clinically diagnosed as yaws seen in
a survey conducted one year after TCT.
The population coverage that was achieved in the Ghanaian population reported here
(89%) was slightly higher than that achieved in the PNG study (84%) [17]. The impact
observed in both studies was very large consisting of a reduction by 90% of active yaws, but in
Ghana we observed a lack of T. pertenue-PCR positive lesions (albeit small number of positives
detected pre-TCT in the Abamkrom subdistrict) which could be related to the higher coverage
rate achieved in Ghana or to the initial lower burden of infection in the present study or both
when compared to PNG.
Recent studies on yaws conducted in PNG [28], Ghana [29], Vanuatu [30] and the Solomon
Islands [31] have identified H. ducreyi as an important cause of skin ulcers in yaws endemic
communities. Isolates of H. ducreyi obtained from skin lesions from children in Ghana are
fully sensitive to azithromycin in vitro and the antibiotic is frequently used to treat chancroid,
a sexually transmitted infection also caused by H. ducreyi. In our study, the overall prevalence
of lesions caused by H. ducreyi was greatly reduced after TCT. However, unlike yaws, the rela-
tive proportion of H. ducreyi-positive ulcers remained essentially unchanged following TCT. It
seems logical to speculate that community mass treatment with azithromycin may have less
impact on lesions caused by this bacterium than those caused by T. pallidum spp. pertenue. We
raise two possible explanations: Firstly, H. ducreyi strains that cause skin lesions in children
may be more infectious than T. pallidum spp. pertenue. Secondly, in common with sexually
transmitted H. ducreyi infections, non-sexual transmission of H. ducreyi does not appear to
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engender protective immunity to subsequent re-infection, unlike the transient immunity that
occurs following treponemal infection [36, 37].
Our study has some limitations. First, the use of school-going children as a sampling meth-
odology may introduce bias because the poorest children, who are at most risk of the disease,
may not attend school. However, school-sampling is generally considered a good and conve-
nient sub-population sample for other NTDs and routine surveillance data from DHIMS2
confirmed the overall decrease of yaws-like cases seen in the sub-district one year after the
mass treatment. Further studies to compare the impact of interventions on school versus com-
munity-based populations are clearly indicated. Second, we selected two different groups of
schools for pre- and post-TCT assessments, rather than returning to the original schools to
determine the impact of TCT on the children who were seen initially. We considered that the
additional survey for clinical and serological screening, and treatment of positive cases, that
these schools would receive was effectively an additional public health intervention that is not
a normal part of the larger interventions that the study aimed to evaluate. We therefore ran-
domly selected a different group of schools for the post-TCT evaluation one year later to avoid
measuring the potential impact of a double treatment. Third, the DPP point-of-care test that
was used in this study lacks some sensitivity at low titres compared with conventional labora-
tory-based testing [23]. However, we believe that since the DPP test is capable of detecting
non-treponemal antibody in more than 90% of cases with RPR titres 1:8 (which have previ-
ously been more closely associated with proven infectious lesions) [17] the benefits of field
testing outweigh the logistics of providing a more reliable laboratory-based service which may
not be readily available in impoverished yaws-endemic regions. Indeed, the lack of sensitivity
of the DPP test at low titre could actually be a benefit since, in this study, confirmed low-titre
RPR seropositivity ( 1:4), which could be missed when using the DPP test, was not associated
with any lesion actively shedding T. pertenue. Finally, to determine the sample size for our sur-
veys, we used a design effect of 2 based on previous experience in the Solomon Islands and Fiji
[34,35], but which is lower than the design effect used in similar studies on NTDs [38]. In our
study, the findings are still statistically strong after accounting for clustering; therefore, we
believe that the design effect used was not a major limitation. However, a comprehensive
review of sampling methods for yaws should be made to provide appropriate guidance for
future intervention studies.
It seems clear, from the results of this intervention study, that yaws-like lesions caused by
H. ducreyi or other unknown pathogens may continue to persist after a single-round of mass
treatment giving the erroneous impression to both the affected population and health author-
ities alike that yaws has not been eliminated from a previously endemic community. This sit-
uation is compounded by the finding that H. ducreyi-positive lesions may be associated with
dually positive non-treponemal and treponemal serological results in children with latent
yaws or serofast status. Azithromycin is one of the antibiotics recommended for the treat-
ment of sexually transmitted H. ducreyi infections [39,40], and it is also effective in the treat-
ment of cutaneous ulcers in children caused by H. ducreyi [41]. In the long term, it may be
necessary to devise appropriate “syndromic” management protocols for non-yaws / non-H.
ducreyi lesions following the successful elimination of yaws through TCT. Further studies on
the etiology of these yaws-like skin lesions in various yaws-endemic regions around the
world are required.
In conclusion, our findings provide additional evidence that one round of TCT with azi-
thromycin with high coverage ~ 90%, as part of the WHO Morges Strategy, is highly effec-
tive in providing a sustained and significant decrease in the prevalence of yaws 12 months
after mass treatment from endemic communities, even if they adjoin other untreated
endemic areas. Because 6-monthly resurveys using field staff may be costly, perhaps, if the
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initial coverage is >90%, in some places, a practical approach is to use trained village volun-
teers for ongoing active community surveillance and health promotion activities for yaws,
especially, in the post-TCT phase similar to the experience of the guinea worm eradication
programme [42]. Although our study is limited in size to allow us to make any firm recom-
mendations regarding the ideal intervals between mass treatment and number of rounds
required to interrupt transmission, we have presented some evidence to support the notion
that with high coverage, a single round of TCT followed by TTT may be adequate and any
additional TCT rounds to interrupt transmission may be carried out at intervals longer than
6 months. Further studies are needed to address these important issues. We also believe that
the point-of-care DPP test applied to a sample of school-going children is a practical and
convenient alternative to laboratory-based serological testing of a sample of the whole popu-
lation to evaluate the effectiveness of yaws interventions in resource-poor settings. How-
ever, in view of the first report of macrolide resistance in yaws [43, 44], vigilance and close
monitoring of cases are required. It is important that health workers to take specimens from
any active skin lesions (papilloma and ulcer) of dually seropositive cases that are not healed
or occur after TCT for PCR testing to definitely confirm yaws and detect any azithromycin
resistance that may emerge among T. pertenue strains and to warrant the treatment of such
cases with benzathine benzylpenicillin.
Supporting information
S1 Table. Deindentified data-set of the pre-TCT survey to estimate seroprevalence of yaws
(Table 1).
(XLSX)
S2 Table. Deindentified data-set of the post-TCT survey to estimate seroprevalence of
yaws (Table 1).
(XLSX)
S3 Table. Deindentified data-set of the pre-TCT survey to determine the etiology of skin
lesions in West Akim district (Table 2).
(XLSX)
S4 Table. Deindentified data-set of the pre-TCT survey to determine the etiology of skin
lesions in Abamkrom sub-district (Table 3).
(XLSX)
S5 Table. Deindentified data-set of the post-TCT survey to determine the etiology of skin
lesions in Abamkrom sub-district (Table 3).
(XLSX)
Acknowledgments
The authors would like to thank all the health workers, community leaders, schoolteachers
and schoolchildren in the Abamkrom sub-district, West Akim District of the Eastern
Region of Ghana for their cooperation and support for the study. We thank Mr Alexei
Mikhailov, Department of Control of Neglected Tropical Diseases, World Health Organiza-
tion, Geneva, Switzerland for creating the maps. The findings and conclusions in this paper
are those of the authors and do not necessarily represent the views of their respective
institutions.
Mass treatment of yaws using azithromycin in Ghana
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006303 March 22, 2018 13 / 16
Author Contributions
Conceptualization: Abdul Aziz Abdulai, Patrick Agana-Nsiire, Cynthia Kwakye-Maclean,
Kwame Amponsa-Achiano, Yaw Adu-Sarkodie, Kingsley Bampoe Asiedu, Ronald C.
Ballard.
Data curation: Patrick Agana-Nsiire, Frank Biney, Kwame Amponsa-Achiano, George
Bonsu.
Formal analysis: Abdul Aziz Abdulai, Patrick Agana-Nsiire, Kwame Amponsa-Achiano, Sergi
Sanz, Ye Tun, Oriol Mitjà, Kingsley Bampoe Asiedu, Ronald C. Ballard.
Investigation: Abdul Aziz Abdulai, Patrick Agana-Nsiire, Frank Biney, Cynthia Kwakye-
Maclean, Shirley Victoria Simpson, George Bonsu, Yaw Adu-Sarkodie, Kennedy Kwasi
Addo, Kai-Hua Chi, Damien Danavall, Cheng Y. Chen, Allan Pillay, Ronald C. Ballard.
Methodology: Kwame Amponsa-Achiano, Kai-Hua Chi, Damien Danavall, Cheng Y. Chen,
Allan Pillay, Ye Tun, Kingsley Bampoe Asiedu, Ronald C. Ballard.
Project administration: Patrick Agana-Nsiire, Sardick Kyei-Faried, Sally-Ann Ohene.
Supervision: Abdul Aziz Abdulai, Patrick Agana-Nsiire, Cynthia Kwakye-Maclean, Sardick
Kyei-Faried, Shirley Victoria Simpson, George Bonsu, Sally-Ann Ohene, William Kwabena
Ampofo, Yaw Adu-Sarkodie, Kennedy Kwasi Addo, Cheng Y. Chen, Allan Pillay, Kingsley
Bampoe Asiedu, Ronald C. Ballard.
Writing – original draft: Abdul Aziz Abdulai, Patrick Agana-Nsiire, Frank Biney, Cynthia
Kwakye-Maclean, Sardick Kyei-Faried, Kwame Amponsa-Achiano, Shirley Victoria Simp-
son, George Bonsu, Sally-Ann Ohene, William Kwabena Ampofo, Yaw Adu-Sarkodie, Ken-
nedy Kwasi Addo, Kai-Hua Chi, Damien Danavall, Cheng Y. Chen, Allan Pillay, Ye Tun,
Kingsley Bampoe Asiedu, Ronald C. Ballard.
Writing – review & editing: Abdul Aziz Abdulai, Patrick Agana-Nsiire, Frank Biney, Cynthia
Kwakye-Maclean, Kwame Amponsa-Achiano, Shirley Victoria Simpson, George Bonsu,
Sally-Ann Ohene, William Kwabena Ampofo, Yaw Adu-Sarkodie, Kennedy Kwasi Addo,
Kai-Hua Chi, Damien Danavall, Cheng Y. Chen, Allan Pillay, Ye Tun, Oriol Mitjà, Kingsley
Bampoe Asiedu, Ronald C. Ballard.
References
1. Giacani L, Lukehart SA. The endemic treponematoses. Clin Microbiol Rev. 2014; 27: 89–115. https://
doi.org/10.1128/CMR.00070-13 PMID: 24396138
2. MitjàO, Marks M, Konan DJP, Ayelo G, Gonzalez-Beiras C, Boua B, et al. Global epidemiology of
yaws: a systematic review. Lancet Glob Health. 2015; 3: e324–31. https://doi.org/10.1016/S2214-109X
(15)00011-X PMID: 26001576
3. Perine PL, Hopkins DR, Niemel PLA, St. John R, Causse G, Antal GM. Handbook of endemic trepone-
matoses: yaws, endemic syphilis and pinta. Geneva: World Health Organization, 1984.
4. MitjàO, Asiedu K, Mabey D. Yaws. Lancet. 2013; 381: 763–73. https://doi.org/10.1016/S0140-6736
(12)62130-8 PMID: 23415015
5. Burke JP, Hopkins DR, Hume JC, Perine PL, John R, editors. Proceedings of an international sympo-
sium on yaws and other endemic treponematoses. Washington DC, 16–18 April 1984. Rev Infect Dis.
1985; 7: S217–S351.
6. Expert Committee on venereal infections and treponematoses (fifth report). Geneva: World Health
Organization (WHO Technical Report Series, No. 190; http://whqlibdoc.who.int/trs/WHO_TRS_190.
pdf).
7. Four decades of achievements: highlights of work of WHO. Geneva: World Health Organization; 1988
(http://www.who.int/yaws/resources/1988_WHO_Yaws_first_decade.pdf).
Mass treatment of yaws using azithromycin in Ghana
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006303 March 22, 2018 14 / 16
8. Zahra A. Yaws eradication campaign in Nsukka Division, Eastern Nigeria. Bull World Health Organ.
1956; 15: 911–935 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538174/pdf/bullwho00534-0050.
pdf). PMID: 13404467
9. Samame GE. Treponematosis eradication, with special reference to yaws eradication in Haiti. Bull
World Health Organ. 1956; 15: 897–910 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538172/pdf/
bullwho00534-0036.pdf). PMID: 13404466
10. Resolution WHA31.58. Control of endemic treponematoses. Geneva: World Health Organization; 1978
(http://www.who.int/neglected_diseases/mediacentre/WHA_31.58_Eng.pdf).
11. Friedrich MJ. WHO declares India free of yaws and maternal and neonatal tetanus. JAMA. 2016; 316:
1141. https://doi.org/10.1001/jama.2016.12649 PMID: 27654592
12. Asiedu K, Fitzpatrick C, Jannin J. Eradication of yaws: historical efforts and achieving WHO’s 2020 tar-
get. PLoS Negl Trop Dis. 2014; 8: e3016. https://doi.org/10.1371/journal.pntd.0003016 PMID:
25254372
13. MitjàO, Hays R, Ipai A, Penias M, Paru R, Fagaho D, et al. Single-dose azithromycin versus benzathine
benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority,
randomised trial. Lancet. 2012; 379: 342–347. https://doi.org/10.1016/S0140-6736(11)61624-3 PMID:
22240407
14. Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for imple-
mentation. Geneva: World Health Organization; 2012 (http://www.who.int/neglected_diseases/
resources/WHO_HTM_NTD_2012.1/en/).
15. Summary report of the consultative meeting on eradication of yaws, 5–7 March 2012, Morges, Switzer-
land. Geneva: World Health Organization; 2012 (http://apps.who.int/iris/bitstream/10665/75528/1/
WHO_HTM_NTD_IDM_2012.2_eng.pdf).
16. Marks M. Yaws: towards the WHO eradication target. Trans R Soc Trop Med Hyg. 2016; 110: 319–
320. https://doi.org/10.1093/trstmh/trw032 PMID: 27268712
17. MitjàO, Houinei W, Moses P, Kapa A, Paru R, Hays R, et al. Mass treatment with single-dose azithro-
mycin for yaws. N Engl J Med 2015; 372: 703–710. https://doi.org/10.1056/NEJMoa1408586 PMID:
25693010
18. Marks M, Sokana O, Nachamkin E, Puiahi E, Kilua G, Pillay A, et al. Prevalence of active and latent
yaws in the Solomon Islands 18 months after azithromycin mass drug administration for trachoma.
PLoS Negl Trop Dis. 2016; 10: e0004927. https://doi.org/10.1371/journal.pntd.0004927 PMID:
27551787
19. Yaws: recognition booklet for communities. Geneva: World Health Organization; 2012 (http://apps.
who.int/iris/bitstream/10665/75360/1/9789241504096_eng.pdf).
20. Agana-Nsiire P, Kaitoo E, Agongo EEA, Bonsu G, Kyei-Faried S, Amponsa-Achiano K, et al. Yaws
prevalence, lessons from the field and the way forward towards yaws eradication in Ghana. Int Sch Res
Notices. 2014; 910937. https://doi.org/10.1155/2014/910937 PMID: 27437507
21. Castro AR, Esfandiari J, Kumar S, Ashton M, Kikkert SE, Park MM, et al. Novel point-of-care test for
simultaneous detection of nontreponemal and treponemal antibodies in patients with syphilis. J Clin
Microbiol. 2010; 48: 4615–4619. https://doi.org/10.1128/JCM.00624-10 PMID: 20881177
22. Ayove T, Houniei W, Wangnapi R, Bieb SV, Kazadi W, et al. Sensitivity and specificity of a rapid point-
of-care test for active yaws: a comparative study. Lancet Glob Health. 2014; 2: e415–21. https://doi.
org/10.1016/S2214-109X(14)70231-1 PMID: 25103395
23. Marks M, Yin YP, Chen XS, Castro A, Causer L, Guy R, et al. Metaanalysis of the performance of a
combined treponemal and nontreponemal rapid diagnostic test for syphilis and yaws. Clin Infect Dis.
2016; 63: 627–633. https://doi.org/10.1093/cid/ciw348 PMID: 27217216
24. Pillay A, Chen C-Y, Reynolds MG, Mombouli JV, Castro AC,Louvoueza D, et al. Laboratory-confirmed
case of yaws in a 10-year-old boy from the Republic of the Congo. J Clin Microbiol. 2011; 49: 4013–
4015. https://doi.org/10.1128/JCM.01121-11 PMID: 21918034
25. Chi KH, Danavall D, Taleo F, Pillay A, Ye T, Nachamkin E, et al. Molecular differentiation of Treponema
pallidum subspecies in skin ulceration clinically suspected as yaws in Vanuatu using real-time multiplex
PCR and serological methods. Am J Trop Med Hyg. 2015; 92: 134–8. https://doi.org/10.4269/ajtmh.14-
0459 PMID: 25404075
26. Marks M, Fookes M, Wagner J, et al. Diagnostics for yaws eradication: insights from direct next genera-
tion sequencing of cutaneous strains of Treponema pallidum. Clin Infect Dis. 2017 Oct 16. https://doi.
org/10.1093/cid/cix892 PMID: 29045605
27. Chen C-Y, Chi K-H, Pillay A, Nachamkin E, Su JR, Ballard RC. Detection of the A2058G and A2059G
23S rRNA gene point mutations associated with azithromycin resistance in Treponema pallidum by use
Mass treatment of yaws using azithromycin in Ghana
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006303 March 22, 2018 15 / 16
of a TaqMan real-time multiplex PCR assay. J Clin Microbiol. 2013; 51: 908–913. https://doi.org/10.
1128/JCM.02770-12 PMID: 23284026
28. MitjàO, Lukehart SA, Pokowas G, Moses P, Kapa A, Godornes C, et al. Haemophilus ducreyi as a
cause of skin ulcers in children from a yaws-endemic area of Papua New Guinea: a prospective cohort
study. Lancet Glob Health. 2014; 2: e235–41. https://doi.org/10.1016/S2214-109X(14)70019-1 PMID:
25103064
29. Ghinai R, El-Duah P, Chi K-H, Pillay A, Solomon AW, Bailey RL, et al. A cross-sectional study of ‘yaws’
in districts of Ghana which have previously undertaken azithromycin mass drug administration for tra-
choma control. PLoS Negl Trop Dis. 2015; 9: e0003496. https://doi.org/10.1371/journal.pntd.0003496
PMID: 25632942
30. Pillay A, Katz SS, Abrams AJ, Ballard RC, Simpson SV, Taleo F, et al. Complete genome sequences of
11 Haemophilus ducreyi isolates from children with cutaneous lesions in Vanuatu and Ghana. Genome
Announc. 2016; 4: e00459–16. https://doi.org/10.1128/genomeA.00459-16 PMID: 27389258
31. Marks M, Chi K-H, Vahi V, Pillay A, Sokana O, Pavluck A, et al. Haemophilus ducreyi associated with
skin ulcers among children, Solomon Islands. Emerg Infect Dis. 2014; 20: 1705–1707. https://doi.org/
10.3201/eid2010.140573 PMID: 25271477
32. Chen CY, Ballard RC. The molecular diagnosis of sexually transmitted genital ulcer disease. Methods
Mol Biol. 2012; 903: 103–112. https://doi.org/10.1007/978-1-61779-937-2_6 PMID: 22782813
33. Rondini S, Mensah-Qaainoo E, Troll H, Bodmer T, Pluschke G. Development and application of real-
time PCR assay for quantification of Mycobacterium ulcerans DNA. J Clin Microbiol. 2003; 41: 4231–
4237. https://doi.org/10.1128/JCM.41.9.4231-4237.2003 PMID: 12958250
34. Marks M, Vahi V, Sokana O et al. Mapping the Epidemiology of Yaws in the Solomon Islands: A Cluster
Randomized Survey. Am J Trop Med Hyg. 2015; 92(1): 129–133. https://doi.org/10.4269/ajtmh.14-
0438 PMID: 25422395
35. Cocks N, Rainima-Qaniuci M, Yalen C, et al. Community seroprevalence survey for yaws and trachoma
in the Western Division of Fiji. Trans R Soc Trop Med Hyg. 2016; 110(10): 582–587. https://doi.org/10.
1093/trstmh/trw069 PMID: 27852877
36. Ballard R, Hook EW III. Syphilis. In: Unemo M, Ballard R, Ison C, Lewis D, Ndowa F, Peeling R, editors.
Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus. Eds.
Geneva: World Health Organization 2013: 107–29.
37. Grenfell B, Bjørnstad O. Sexually transmitted diseases: epidemic cycling and immunity. Nature. 2005;
433: 366–367. https://doi.org/10.1038/433366a PMID: 15674273
38. Ngondi J, Reacher M, Matthews F, Brayne C, Emerson P. Trachoma survey methods: a literature
review. Bull World Health Organ. 2009; 87(2): 143–151. https://doi.org/10.2471/BLT.07.046326 PMID:
19274367
39. Ballard RC, Ye H, Matta A, Dangor Y, Radebe F. Treatment of chancroid with azithromycin. Int J STD
AIDS. 1996; 7(Suppl.1): 9–12. https://doi.org/10.1258/0956462961917230 PMID: 8652728
40. Sexually transmitted diseases: treatment guidelines. MMWR Recomm Rep. 2015; 64(RR3):26 (http://
www.cdc.gov/mmwr/pdf/rr/rr6403.pdf).
41. Gonza´lez-Beiras C, Kapa A, Vall Mayans M, et al. Single dose azithromycin for the treatment of Haemo-
philus ducreyi skin ulcers in Papua New Guinea. Clin Infect Dis 2017; published online Aug 16. https://
doi.org/10.1093/cid/cix723.
42. Fitzpatrick C, Sankara DP, Agua JF, Jonnalagedda L, Rumi F, Weiss A, et al. The cost-effectiveness of
an eradication programme in the end game: Evidence from guinea worm disease. PLoS Negl Trop Dis
2017; 11(10): e0005922 https://doi.org/10.1371/journal.pntd.0005922 PMID: 28981510
43. Sˇ majs David, Pospı´sˇilova´ Petra. Macrolide resistance in yaws. Lancet 2018; published online Feb 7.
https://doi.org/10.1016/S0140-6736(18)30205-8
44. MitjàO, Godornes C, Houinei W, Kapa August, Paru Raymond, Abel Haina et al. Re-emergence of
yaws after single, mass azithromycin treatment followed by targeted treatment: a longitudinal study.
Lancet 2018; published online Feb 7. http://dx.doi.org/10.1016/S0140-6736(18)30204-6
Mass treatment of yaws using azithromycin in Ghana
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006303 March 22, 2018 16 / 16
